Canada introduces prescription extended-release melatonin for children with autism and Smith-Magenis syndrome

A new prescription extended-release melatonin medication called Slenyto has now become available across Canada, offering a targeted treatment option for sleep problems in children and adolescents with autism spectrum disorder and Smith-Magenis syndrome. A prescription melatonin treatment for children and…













